<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="/resources/spdi-openaccess-jats.xsl"?>
<!DOCTYPE response [
	
<!ENTITY % article SYSTEM "http://jats.nlm.nih.gov/archiving/1.2/JATS-archivearticle1.dtd">
<!ENTITY % book-part-wrapper SYSTEM "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
	]><response><apiMessage>This XML was provided by Springer Nature</apiMessage><query>doi:10.1186/s12981-019-0232-4</query><apiKey>6b19ee21fe6a243741a528650f7c8997</apiKey><result><total>1</total><start>1</start><pageLength>1</pageLength><recordsDisplayed>1</recordsDisplayed></result><records><article dtd-version="1.2" article-type="research-article" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><?properties open_access?><front><journal-meta><journal-id journal-id-type="publisher-id">12981</journal-id><journal-title-group><journal-title>AIDS Research and Therapy</journal-title><abbrev-journal-title abbrev-type="publisher">AIDS Res Ther</abbrev-journal-title></journal-title-group><issn pub-type="epub">1742-6405</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">s12981-019-0232-4</article-id><article-id pub-id-type="manuscript">232</article-id><article-id pub-id-type="doi">10.1186/s12981-019-0232-4</article-id><article-categories><subj-group subj-group-type="heading"><subject>Case Report</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Primary cutaneous actinomycosis: a diagnosis consideration in people living with HIV/AIDS</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="Au1"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1525-8130</contrib-id><name><surname>Khadka</surname><given-names>Priyatam</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="corresp" rid="IDs1298101902324_cor1">a</xref></contrib><contrib contrib-type="author" id="Au2"><name><surname>Koirala</surname><given-names>Soniya</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution content-type="org-division">Department of Microbiology</institution><institution content-type="org-name">Sumeru Hospital</institution></institution-wrap><addr-line content-type="city">Lalitpur</addr-line><country country="NP">Nepal</country></aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2114 6728</institution-id><institution-id institution-id-type="GRID">grid.80817.36</institution-id><institution content-type="org-name">Tribhuvan University</institution></institution-wrap><addr-line content-type="street">Tri-Chandra Multiple Campus</addr-line><addr-line content-type="city">Ghantaghar, Kathmandu</addr-line><country country="NP">Nepal</country></aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0635 3456</institution-id><institution-id institution-id-type="GRID">grid.412809.6</institution-id><institution content-type="org-division">Department of Dermatology and Venerology</institution><institution content-type="org-name">Tribhuvan University Teaching Hospital</institution></institution-wrap><addr-line content-type="city">Kathmandu</addr-line><country country="NP">Nepal</country></aff></contrib-group><author-notes><corresp id="IDs1298101902324_cor1"><label>a</label><email>khadka.priyatam@gmail.com</email></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>30</day><month>7</month><year>2019</year></pub-date><pub-date date-type="collection" publication-format="electronic"><month>12</month><year>2019</year></pub-date><volume>16</volume><issue seq="16">1</issue><elocation-id>16</elocation-id><history><date date-type="registration"><day>19</day><month>7</month><year>2019</year></date><date date-type="received"><day>9</day><month>4</month><year>2019</year></date><date date-type="accepted"><day>19</day><month>7</month><year>2019</year></date><date date-type="online"><day>30</day><month>7</month><year>2019</year></date></history><permissions><copyright-statement>© The Author(s) 2019</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link xlink:href="http://creativecommons.org/licenses/by/4.0/" ext-link-type="url">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link xlink:href="http://creativecommons.org/publicdomain/zero/1.0/" ext-link-type="url">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1" xml:lang="en"><title>Abstract</title><sec id="ASec1"><title>Background</title><p id="Par1">Owing to similar clinical presentations, as of cutaneous disease of different etiologies, and extreme rarity in the global incidence; primary cutaneous actinomycosis often remains as diagnostic challenges.</p></sec><sec id="ASec2"><title>Case presentation</title><p id="Par2">Herein, we describe a case of primary cutaneous actinomycosis, erroneously treated as cutaneous tuberculosis, in a patient living with AIDS. On clinical examination, the characteristic lesion, resembling cutaneous tuberculosis, observed on the dorsum of a left leg. No other lesion elsewhere on the body was observed, however. Cytological examinations of the stabbed biopsy were negative for malignant cells; although hyper-keratosis and mild-acanthosis of epidermis, acute inflammatory infiltrates comprising plasma cell, macrophages and neutrophils were observed in the upper and mid dermis. The pus aspirated from lesion grew a molar tooth, adherent colonies in microaerophilic condition. Further, identifications and susceptibility pattern against recommended antibiotics were assessed as per the CLSI (Clinical and Laboratory Standard Institute) guidelines. Subsequently, the case was then, diagnosed as primary cutaneous actinomycosis. Radiographic imaging of abdomen and lungs were normal; no feature of disseminated actinomycosis seen. Penicillin G followed by Penicillin V, was prescribed for 12 months. The patient underwent progressive changes and no relapse noted on periodic follow-up.</p></sec><sec id="ASec3"><title>Conclusion</title><p id="Par3">The case underscores cutaneous actinomycosis requires a diagnosis consideration, especially in People Living with HIV/AIDS (PLHA), where myriad of opportunistic cutaneous infections are common.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Diagnostic consideration</kwd><kwd>Penicillin</kwd><kwd>Primary cutaneous actinomycosis</kwd><kwd>AIDS</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>publisher-imprint-name</meta-name><meta-value>BioMed Central</meta-value></custom-meta><custom-meta><meta-name>volume-issue-count</meta-name><meta-value>1</meta-value></custom-meta><custom-meta><meta-name>issue-article-count</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>issue-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>issue-pricelist-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-holder</meta-name><meta-value>The Author(s)</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>article-contains-esm</meta-name><meta-value>No</meta-value></custom-meta><custom-meta><meta-name>article-numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-month</meta-name><meta-value>7</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-day</meta-name><meta-value>19</meta-value></custom-meta><custom-meta><meta-name>article-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>volume-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>journal-product</meta-name><meta-value>ArchiveJournal</meta-value></custom-meta><custom-meta><meta-name>numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-grants-type</meta-name><meta-value>OpenChoice</meta-value></custom-meta><custom-meta><meta-name>metadata-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>abstract-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodypdf-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodyhtml-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bibliography-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>esm-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>online-first</meta-name><meta-value>false</meta-value></custom-meta><custom-meta><meta-name>pdf-file-reference</meta-name><meta-value>BodyRef/PDF/12981_2019_Article_232.pdf</meta-value></custom-meta><custom-meta><meta-name>target-type</meta-name><meta-value>OnlinePDF</meta-value></custom-meta><custom-meta><meta-name>issue-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>article-type</meta-name><meta-value>OriginalPaper</meta-value></custom-meta><custom-meta><meta-name>journal-subject-primary</meta-name><meta-value>Medicine &amp; Public Health</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Infectious Diseases</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Virology</meta-value></custom-meta><custom-meta><meta-name>journal-subject-collection</meta-name><meta-value>Medicine</meta-value></custom-meta><custom-meta><meta-name>open-access</meta-name><meta-value>true</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par12">Actinomycosis is an unusual sub-acute or chronic suppurative and granulomatous bacterial infection characterized by multiple abscesses, tissue fibrosis, and the formation of sinuses and fistulae [<xref ref-type="bibr" rid="CR1">1</xref>]. The culprits ensuing the infection, <italic>Actinomyces</italic> spp., are the aerobic or micro-aerophilic filamentous gram-positive bacilli which basically colonized in oropharynx, gastrointestinal tract and uro-genital tract [<xref ref-type="bibr" rid="CR1">1</xref>–<xref ref-type="bibr" rid="CR3">3</xref>]. Despite, the indigenous habitat of the pathogen, a few cases of actinomycosis inflicting bone and joints, skin and soft tissue, CNS, respiratory tract, digestive tract can be found on a literature search [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. Of reported clinical manifestations, disseminated forms, originating from other colonized sites, are likely occurring; however, primary actinomycosis involving only principle site i.e. extremities is extremely rare [<xref ref-type="bibr" rid="CR3">3</xref>–<xref ref-type="bibr" rid="CR5">5</xref>].</p><p id="Par13">It is somewhat surprising, the reported incidence of actinomycosis in PLHA has remained low; nevertheless, the persistent impairment in both cellular and humoral immunity are more obvious, due to HIV (human immunodeficiency virus) [<xref ref-type="bibr" rid="CR6">6</xref>]. The reason for this is not clear, nonetheless, can be speculated due to misdiagnosis. The misdiagnosis often occurs, particularly in PLHA where myriads of other infections are more common, owing to similar indolent and non-specific clinical manifestations of actinomycosis which masquerades as infections of other etiologies [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. With this backdrop, herein, we report a case of primary cutaneous actinomycosis, mimicking as cutaneous tuberculosis, in a patient living with HIV/AIDS.</p></sec><sec id="Sec2"><title>Case presentation</title><p id="Par14">A 42-year-old farmer presented to the Dermatology out-patient department (OPD), Sumeru Hospital, a tertiary care hospital in Kathmandu, with the complaint of a large hard lesion that with time multiplied gradually and had multiple openings discharging pus. He had lived with HIV for 6 years and was from middle-class socio-economic status. Besides, no previous history of systemic illness and major surgical interventions was described. Although, he reported being bitten by own dog earlier 1 month ago on same foot, before the lesion first appears. Based upon the clinical presentations and unresolved lesion with extended courses of antimicrobial therapy (cloxacillin), the previous diagnosis was made as cutaneous tuberculosis, from the local hospital; was treated with anti-tubercular treatment (ATT) for 4 months. Inconsistently, the lesions continued to progress with pus and bloody discharges. On clinical examination, the patient had a large plaque-like lesion about 10 cm × 6 cm overlying skin with papules and nodules on the dorsum of a left leg (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). Over the lesion, multiple discharging sinuses draining sero-sanguinous fluid were scattered. No other lesion elsewhere on the body was observed, however. His neurovascular status of the foot was normal with no associated regional lymphadenopathy. Scrutinizing these clinical presentations and clinical history, the differential diagnosis of rifampicin-resistant cutaneous tuberculosis, mycetoma/madura foot, and cutaneous nocardiosis was made.<fig id="Fig1"><label>Fig. 1</label><caption xml:lang="en"><p>Large plaque-like lesion about 10 cm × 6 cm with papules and nodules; multiple discharging sinuses draining sero-sanguinous fluid</p></caption><p><graphic specific-use="HTML" mime-subtype="JPEG" xlink:href="MediaObjects/12981_2019_232_Fig1_HTML.jpg" id="MO1"/></p></fig></p></sec><sec id="Sec3"><title>Investigation</title><p id="Par15">Histopathological examination, of stabbed biopsy, revealed hyper-keratosis and mild-acanthosis of the epidermis, while acute inflammatory infiltrates comprising plasma cell, macrophages and neutrophils were observed in the upper and mid dermis. Peripheral blood smear portrayed normal cell morphology, normal hemoglobin level (13 gm/dL); while, WBC (12,400/mL) and platelets (4, 15,200/µL) count were slightly elevated. Serological test for HBsAg and HCV were non-reactive; although, HIV was positive (ELISA) with drop off CD4 count 128 cell/µL.</p><p id="Par16">The presumptive identification of etiologies was done with gram staining from the lesion which revealed branching filamentous gram-positive bacteria suggestive <italic>Actinomyces</italic> spp. (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). As of further microbiological approaches, the cultured pus aspirate grew molar tooth shaped adherent colonies after 72 h of incubation at 36 °C on blood agar and chocolate agar in presence of ambient air, 5% Co<sub>2</sub> (Figs. <xref rid="Fig3" ref-type="fig">3</xref>, <xref rid="Fig4" ref-type="fig">4</xref>). Since molecular analysis and sequencing was not accessible in our laboratory setting; further, identification of the isolate, <italic>Actinomyces israeli</italic>, was done with standard microbiological culture methods as recommended by American Society for Microbiology based upon phenotypic characteristics and biochemical interpretations [<xref ref-type="bibr" rid="CR8">8</xref>]. In brief, colony morphology (chalky, matt, dry, crumbly, adherent in appearances; 0.5–2.0 mm in diameter with fine intertwining, branching filaments); in-house set of biochemical test: pigmentation (negative), catalase (negative), nitrate reduction (positive), hydrolysis of urea (negative) while esculin (positive), production of α-glucosidase and β-galactosidase (positive) while α-fucosidase and β-NAG (negative), fermentation of arabinose, maltose, raffinose, rhamnose, sucrose, xylose, trehalose (positive) while mannitol (negative). The antimicrobial susceptibility testing was done by modified Kirby-baur disc diffusion method on blood agar against commercially prepared antibiotic disks (Hi-Media Laboratories, Pvt, limited, India) in compliance with Clinical Laboratory Standards Institute (CLSI). The isolate was sensitive to penicillin G, amoxicillin, ceftriaxone, meropenem, doxycycline, linezolid, clindamycin, while ciprofloxacin and erythromycin were found resistant. Gene Xpert testing from the pus sample was negative for <italic>Mycobacterium tuberculosis</italic> with no associated resistant gene. No fungal elements grew from the pus aspirate; blood and urine sample were sterile.<fig id="Fig2"><label>Fig. 2</label><caption xml:lang="en"><p>Gram stain: gram positive branching filamentous bacteria suggestive <italic>Actinomyces</italic> spp. (×1000 orginal magnification)</p></caption><p><graphic specific-use="HTML" mime-subtype="JPEG" xlink:href="MediaObjects/12981_2019_232_Fig2_HTML.jpg" id="MO2"/></p></fig><fig id="Fig3"><label>Fig. 3</label><caption xml:lang="en"><p>Colonial morphology of <italic>Actinomyces israelii</italic> on blood agar: whitish chalky adherent colonies with molar tooth appearance</p></caption><p><graphic specific-use="HTML" mime-subtype="JPEG" xlink:href="MediaObjects/12981_2019_232_Fig3_HTML.jpg" id="MO3"/></p></fig><fig id="Fig4"><label>Fig. 4</label><caption xml:lang="en"><p>Colonial morphology of <italic>Actinomyces israelii</italic> on chocolate agar: whitish chalky adherent colonies with molar tooth appearance</p></caption><p><graphic specific-use="HTML" mime-subtype="JPEG" xlink:href="MediaObjects/12981_2019_232_Fig4_HTML.jpg" id="MO4"/></p></fig></p><p id="Par17">Additionally, CT scan of abdomen and chest was done to rule-out possible disseminated actinomycosis; conversely, no abnormalities detected. In view of clinical manifestations and investigation reports, a diagnosis of primary cutaneous actinomycosis was made in HIV positive patient. After then, anti-tubercular therapy was discontinued and the patient was treated with intravenous benzylpenicillin (Penicillin G) for 6 weeks followed by oral phenoxymethylpenicillin (Penicillin V) for another 6 weeks.</p></sec><sec id="Sec4"><title>Treatment</title><p id="Par18">The patient was treated with penicillin G–24 million U/d intravenous by continuous infusion for 6 weeks; and then shifted to oral penicillin V for another 6 weeks then to follow. The oral penicillin was continued up to 12 months.</p></sec><sec id="Sec5"><title>Outcomes and follow-up</title><p id="Par19">He has now completed 3 months of antimicrobial therapy; has undergone progressive changes—flattening and regression of the indurated lesion observed—no sign of relapse noted (Fig. <xref rid="Fig5" ref-type="fig">5</xref>). The oral penicillin V continued for a year to limit the possible late relapse. Now, the lesion healed completely without recur.<fig id="Fig5"><label>Fig. 5</label><caption xml:lang="en"><p>Flattening and regression of the indurated lesion after 3 months of antimicrobial therapy (Penicillin)</p></caption><p><graphic specific-use="HTML" mime-subtype="JPEG" xlink:href="MediaObjects/12981_2019_232_Fig5_HTML.jpg" id="MO5"/></p></fig></p></sec><sec id="Sec6"><title>Literature search</title><p id="Par20">All the relevant information presented in table and literature review included in the manuscript was collected via searching Google, Pub Med/NCBI and other similar databases from 1986 to 2017. Key search terms were actinomycosis, HIV/AIDS, diagnosis consideration and clinical management (Table <xref rid="Tab1" ref-type="table">1</xref>) [<xref ref-type="bibr" rid="CR9">9</xref>–<xref ref-type="bibr" rid="CR25">25</xref>].<table-wrap id="Tab1"><label>Table 1</label><caption xml:lang="en"><p>Summary of actinomycosis and its clinical management in patient living with HIV/AIDS patient, reported in English-language literature</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"><p>S. no</p></th><th align="left"><p>References</p></th><th align="left"><p>CD4 count/µL</p></th><th align="left"><p>Surgical intervention</p></th><th align="left"><p>Antimicrobial therapy</p></th><th align="left"><p>Treatment duration</p></th><th align="left"><p>Outcomes</p></th></tr></thead><tbody><tr><td align="left" colspan="7"><p>Cervicofacial actinomycosis</p></td></tr><tr><td align="left"><p>1</p></td><td align="left"><p>Yeager et al. [<xref ref-type="bibr" rid="CR9">9</xref>]</p></td><td align="left"><p>NA</p></td><td align="left"><p>Not done</p></td><td align="left"><p>Penicillin G (IV) + oral penicillin</p></td><td align="left"><p>Penicillin-G = 6 weeks; oral penicillin = 3 months</p></td><td align="left"><p>Cured</p></td></tr><tr><td align="left"><p>2</p></td><td align="left"><p>Watkins et al. [<xref ref-type="bibr" rid="CR10">10</xref>]</p></td><td align="left"><p>NA</p></td><td align="left"><p>Edematous soft tissue and sequestrum were removed</p></td><td align="left"><p>Penicillin G (IV)</p></td><td align="left"><p>6 weeks</p></td><td align="left"><p>Cured</p></td></tr><tr><td align="left"><p>3</p></td><td align="left"><p>Manfredi et al. [<xref ref-type="bibr" rid="CR11">11</xref>]</p></td><td align="left"><p>case 1(11); case 2(4)</p></td><td align="left"><p>Surgical debridement of tissue</p></td><td align="left"><p>Itraconazole + ceftazidime + netilmicin</p></td><td align="left"><p>Few weeks</p></td><td align="left"><p>Died</p></td></tr><tr><td align="left"><p>4</p></td><td align="left"><p>Kingdom et al. [<xref ref-type="bibr" rid="CR12">12</xref>]</p></td><td align="left"><p>499</p></td><td align="left"><p>Not done</p></td><td align="left"><p>Oral penicillin</p></td><td align="left"><p>3 months</p></td><td align="left"><p>Cured</p></td></tr><tr><td align="left"><p>5</p></td><td align="left"><p>Manfredi et al. [<xref ref-type="bibr" rid="CR13">13</xref>]</p></td><td align="left"><p>(case 1)9</p></td><td align="left"><p>Surgical debridement of tissue</p></td><td align="left"><p>Fluconazole. Ceftriaxone, netilmicin, itraconazole and ceftazidime</p></td><td align="left"><p>Few days</p></td><td align="left"><p>Died</p></td></tr><tr><td align="left"/><td align="left"/><td align="left"><p>(case 2)2</p></td><td align="left"><p>Surgical debridement of tissue</p></td><td align="left"><p>Fluconazole, ceftriaxone, netilmicin, itraconazole, piperacillin and clindamycin</p></td><td align="left"><p>45 days</p></td><td align="left"><p>Died</p></td></tr><tr><td align="left"><p>6</p></td><td align="left"><p>Vazquez et al. [<xref ref-type="bibr" rid="CR14">14</xref>]</p></td><td align="left"><p>480</p></td><td align="left"><p>Surgical incision of the tissue</p></td><td align="left"><p>Oral amoxycillin</p></td><td align="left"><p>3 weeks</p></td><td align="left"><p>Cured</p></td></tr><tr><td align="left"><p>7</p></td><td align="left"><p>Spadari et al. [<xref ref-type="bibr" rid="CR15">15</xref>]</p></td><td align="left"><p>NA</p></td><td align="left"><p>Not done</p></td><td align="left"><p>Oral doxycycline (patient was penicillin allergic)</p></td><td align="left"><p>2 months</p></td><td align="left"><p>Died</p></td></tr><tr><td align="left"><p>8</p></td><td align="left"><p>Yuria et al. [<xref ref-type="bibr" rid="CR16">16</xref>]</p></td><td align="left"><p>63</p></td><td align="left"><p>Not done</p></td><td align="left"><p>Intravenous ampicillin</p></td><td align="left"><p>2 weeks</p></td><td align="left"><p>Cured</p></td></tr><tr><td align="left"><p>9</p></td><td align="left"><p>Sudhakar et al. [<xref ref-type="bibr" rid="CR17">17</xref>]</p></td><td align="left"><p>82</p></td><td align="left"><p>Not done</p></td><td align="left"><p>Ampicillin salbactam (IV) + amoxycillin–clavulanic acid</p></td><td align="left"><p>Ampicillin salbactam (IV) = 4 days; amoxycillin–clavulanic acid = 5 days</p></td><td align="left"><p>Cured</p></td></tr><tr><td align="left"><p>10</p></td><td align="left"><p>Klein et al. [<xref ref-type="bibr" rid="CR18">18</xref>]</p></td><td align="left"><p>367</p></td><td align="left"><p>Removed maxillary bone sequestration</p></td><td align="left"><p>Penicillin G (IV) + amoxycillin</p></td><td align="left"><p>Penicillin G (IV) = 3 weeks; oral amoxicillin = 6 months</p></td><td align="left"><p>Cured</p></td></tr><tr><td align="left" colspan="7"><p>Thoracic actinomycosis</p></td></tr><tr><td align="left"><p>11</p></td><td align="left"><p>Cendan et al. [<xref ref-type="bibr" rid="CR19">19</xref>]</p></td><td align="left"><p>NA</p></td><td align="left"><p>Not done</p></td><td align="left"><p>Penicillin G</p></td><td align="left"><p>4 weeks</p></td><td align="left"><p>Died</p></td></tr><tr><td align="left" colspan="7"><p>Pulmonary actinomycosis</p></td></tr><tr><td align="left"><p>12</p></td><td align="left"><p>Tabarsi et al. [<xref ref-type="bibr" rid="CR20">20</xref>]</p></td><td align="left"><p>NA</p></td><td align="left"><p>Upper lobectomy</p></td><td align="left"><p>Oral penicillin; clindamycin, metronidazole, trimethoprim/sulfamethoxazole (TMP–SMX) and ceftriaxone were added to Highly Active Antiretroviral Therapy (HAART)</p></td><td align="left"><p>6 months</p></td><td align="left"><p>Cured</p></td></tr><tr><td align="left" colspan="7"><p>Gastro interstinal actinomycosis </p></td></tr><tr><td align="left"><p>13</p></td><td align="left"><p>Spencer et al. [<xref ref-type="bibr" rid="CR21">21</xref>]</p></td><td align="left"><p>NA</p></td><td align="left"><p>Not done</p></td><td align="left"><p>Antacids and ketoconazole</p></td><td align="left"><p>Not described</p></td><td align="left"><p>Cured</p></td></tr><tr><td align="left"><p>14</p></td><td align="left"><p>Litt et al. [<xref ref-type="bibr" rid="CR22">22</xref>]</p></td><td align="left"><p>100</p></td><td align="left"><p>Not done</p></td><td align="left"><p>Oral penicillin</p></td><td align="left"><p>5 months</p></td><td align="left"><p>Cured</p></td></tr><tr><td align="left"><p>15</p></td><td align="left"><p>Arora et al. [<xref ref-type="bibr" rid="CR23">23</xref>]</p></td><td align="left"><p>4</p></td><td align="left"><p>Not done</p></td><td align="left"><p>Intravenous penicillin + fluconazole</p></td><td align="left"><p>4 weeks</p></td><td align="left"><p>Died with other cause</p></td></tr><tr><td align="left"><p>16</p></td><td align="left"><p>Redelman et al. [<xref ref-type="bibr" rid="CR24">24</xref>]</p></td><td align="left"><p>22</p></td><td align="left"><p>Not done</p></td><td align="left"><p>Doxycycline (IV) (the patient was allergic to penicillin)</p></td><td align="left"><p>4 months</p></td><td align="left"><p>Died with other cause</p></td></tr><tr><td align="left" colspan="7"><p>Primary cutaneous actinomycosis (lower extermities)</p></td></tr><tr><td align="left"><p>17</p></td><td align="left"><p>Gomes et al. [<xref ref-type="bibr" rid="CR25">25</xref>]</p></td><td align="left"><p>123</p></td><td align="left"><p>Wound debridement</p></td><td align="left"><p>Trimethoprim + sulfomethoxazole + ART (emtricitabina + tenofovir, ritonavir, and darunavir)</p></td><td align="left"><p>4 months</p></td><td align="left"><p>Cured</p></td></tr></tbody></table><table-wrap-foot><p><italic>ART</italic> antiretroviral therapy, <italic>IV</italic> intra-venous, <italic>HAART</italic> highly active antiretroviral therapy, <italic>TMP–SMX</italic> trimethoprim/sulfamethoxazole</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec7" sec-type="discussion"><title>Discussion</title><p id="Par21">The emergence of HIV and the onset of AIDS epidemic have been associated with a myriad of opportunistic cutaneous infections; however, the cutaneous actinomycosis is out-of-the limelight from the differential diagnosis. The masquerading clinical presentations as cutaneous tuberculosis, fungal infections, malignancies and other systemic infections, difficult in vitro cultivation of the pathogen, and non-specific radiological picture are commonly associated outfits leading misdiagnosis [<xref ref-type="bibr" rid="CR6">6</xref>]. In our case, the primordial diagnosis was made as cutaneous tuberculosis, based upon the clinical presentations and unresolved lesion with extended courses of antimicrobial therapy (cloxacillin). Further, unresolved lesion, even after the anti-tubercular therapy implies a differential diagnosis of rifampicin-resistant cutaneous tuberculosis, mycetoma/madura foot, and cutaneous nocardiosis.</p><p id="Par22">Relating the endogenous habitat or colonization of the pathogen, <italic>Actinomyces israelii</italic>, the primary cutaneous actinomycosis of a lower extremity is extremely rare; associated either with post-traumatic exposure or direct implantation of the pathogen via animal, insects or human bites [<xref ref-type="bibr" rid="CR26">26</xref>–<xref ref-type="bibr" rid="CR28">28</xref>]. Linking the common ground of infection acquisition, probably the pathogen could have inoculated from the dog bites since no other clinical history suggesting sourced pathogen reported. No detectable extra-cutaneous lesions and radiological picture portentous to the dissemination were observed.</p><p id="Par23">Moreover, difficulties in in vitro cultivation of the pathogen attribute further diagnostic challenges; since, longer incubation, up to 10 days, is obligatory prior to be reported as sterile [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. Earlier, the presumptive diagnosis could have made at least with gram staining in the local hospital; despite, relying only upon clinical manifestations; which inturn could prevent the erroneous diagnosis and treatment. Needless to say, but it is the ground reality of clinical practice, in developing countries like Nepal. The identification of the etiology, <italic>Actinomyces israelii</italic>, was done by standard microbiological culture methods as recommended by the American Society for Microbiology based upon: phenotypic characteristics of the isolate, its antimicrobial susceptibility pattern against antibiotics, extended incubation period and biochemical interpretations; sequencing of 16SrRNA, however, was not available in our setting [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>]. Therefore, prior to starting the antimicrobial therapy, a high index of clinical suspicion together with close collaboration with microbiological interpretations is of utmost importance, for successful outcomes.</p><p id="Par24">For successful management and treatment in cutaneous actinomycosis—limiting possible late relapse: early detection of the pathogen, recommended surgical debridement along with the appropriate selection of antimicrobial therapy, correct dosing, and treatment duration; are crucial [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. High-dose of penicillin over a prolonged period, 6 months to 1 year, is presumed as the drug of choice for all forms of actinomycosis [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. As an alternative to penicillin, if the patient is hypersensitive to penicillin or if etiologies are resistant to penicillin, the antibiotics such as clindamycin, erythromycin, tetracycline, doxycycline, ceftriaxone, and chloramphenicol could be opted [<xref ref-type="bibr" rid="CR32">32</xref>–<xref ref-type="bibr" rid="CR34">34</xref>]. However, the clinicians must be cautious while opting the antibiotics: metronidazole, aminoglycosides, aztreonam, co-trimoxazole (TMP–SMX), penicillinase-resistant penicillins (e.g., methicillin, nafcillin, oxacillin, cloxacillin), and cephalexin, since these antibiotics possess nearly no activity against <italic>Actinomyces</italic> spp. [<xref ref-type="bibr" rid="CR33">33</xref>.]. Unfolding to our case, no progressive changes on the lesion occurred; since as implicated antibiotic therapy i.e. cloxacillin was opted, initially. Although, on shifting to penicillin the patient undergone progressive changes; lesion healed subsequently and no relapse noted. Therefore, it is mandatory that the therapeutic regimen should be customized for each patient depending upon the susceptibility of the pathogen against the antibiotics.</p><p id="Par25">The adverse reaction, nevertheless, owing to prolonged and high dose of penicillin therapy, are common including pseudomembranous colitis, interstitial nephritis, epigastric distress, urticarial, leukopenia, allergic reactions, eosinophilia, and super-infection [<xref ref-type="bibr" rid="CR35">35</xref>]. No such side effects were found to be associated in our case, however. The patient reported a few episodes of nausea, vomiting, and diarrhea during 12 months of medication as minimal side effects.</p></sec><sec id="Sec8" sec-type="conclusions"><title>Conclusion</title><p id="Par26">In clinical practice, the cutaneous actinomycosis often outfits with diagnostic challenges, owing to the multifaceted clinic-pathological features as of cutaneous infection with different etiology, and inherent difficulty in in vitro cultivating. Therefore, cutaneous actinomycosis requires a diagnosis consideration, especially in PLHA, where myriad of opportunistic cutaneous infections are common.</p></sec></body><back><ack><title>Acknowledgements</title><p>We would like to thanks Mr. Pradeep Sharma (Civil Service Hospital) his tremendous technical support.</p></ack><sec sec-type="author-contribution"><title>Authors’ contributions</title><p>PK conceived the study, design the manuscript, review of the literature. SK reviewed the manuscript and gave the concept of the research paper and critically reviewed the manuscript. Both authors read and approved the final manuscript.</p></sec><sec><title>Funding</title><p>No funding source.</p></sec><sec sec-type="data-availability"><title>Availability of data and materials</title><p>All data generated or analyzed during this study are included in this published article.</p></sec><sec sec-type="ethics-statement"><sec id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par27">There is no need for ethical approval for a case report according to the local ethical guidelines. Written informed consent was obtained from the patient for granting participation in an interview and to extract pertinent socio-demographic and clinical data from their respective clinical files, respecting confidentiality.</p></sec><sec id="FPar2"><title>Consent for publication</title><p id="Par28">Written informed consent was obtained from the patient for publication of this case report and any accompanying images.</p></sec><sec id="FPar3"><title>Competing interest</title><p id="Par29">The authors declare that they have no competing interests.</p></sec></sec><ref-list id="Bib1"><title>References</title><ref-list><ref id="CR1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lustig</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">Actinomycosis: etiology, clinical features, diagnosis, treatment, and management</article-title><source>Infect Drug Resist.</source><year>2014</year><volume>7</volume><fpage>183</fpage><lpage>197</lpage><pub-id pub-id-type="pmid">25045274</pub-id><pub-id pub-id-type="pmcid">4094581</pub-id></mixed-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabbe</surname><given-names>LJ</given-names></name><name><surname>Van De Merwe</surname><given-names>D</given-names></name><name><surname>Schouls</surname><given-names>L</given-names></name><name><surname>Bergmans</surname><given-names>A</given-names></name><name><surname>Vaneechoutte</surname><given-names>M</given-names></name><name><surname>Vandamme</surname><given-names>P</given-names></name></person-group><article-title xml:lang="en">Clinical spectrum of infections due to the newly described</article-title><source>J Clin Microbiol.</source><year>1999</year><volume>37</volume><issue>1</issue><fpage>8</fpage><lpage>13</lpage><pub-id pub-id-type="coi">1:STN:280:DyaK1M7gt1Cgtw%3D%3D</pub-id><pub-id pub-id-type="pmid">9854055</pub-id><pub-id pub-id-type="pmcid">84153</pub-id></mixed-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Könönen</surname><given-names>E</given-names></name><name><surname>Wade</surname><given-names>WG</given-names></name></person-group><article-title xml:lang="en">Actinomyces and related organisms in human infections</article-title><source>Clin Microbiol Rev</source><year>2015</year><volume>28</volume><issue>2</issue><fpage>419</fpage><lpage>442</lpage><pub-id pub-id-type="doi">10.1128/CMR.00100-14</pub-id></mixed-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inamadar</surname><given-names>AC</given-names></name><name><surname>Palit</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Study Primary cutaneous nocardiosis: a case study and review</article-title><source>Send to Indian J Dermatol Venereol Leprol.</source><year>2003</year><volume>69</volume><issue>6</issue><fpage>386</fpage><lpage>391</lpage><pub-id pub-id-type="coi">1:STN:280:DC%2BD2svisFSmsQ%3D%3D</pub-id></mixed-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sonam Sharma</surname><given-names>RS</given-names></name><name><surname>Sharma</surname><given-names>SC</given-names></name></person-group><article-title xml:lang="en">Primary cutaneous actinomycosis of the lower extremity: a clinical</article-title><source>J Orthop Surg Rehabil.</source><year>2017</year><volume>1</volume><issue>2</issue><fpage>1</fpage><lpage>4</lpage></mixed-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaudhry</surname><given-names>SI</given-names></name><name><surname>Greenspan</surname><given-names>JS</given-names></name></person-group><article-title xml:lang="en">Actinomycosis in HIV infection: a review of a rare complication</article-title><source>Int J STD AIDS</source><year>2000</year><volume>11</volume><issue>6</issue><fpage>349</fpage><lpage>355</lpage><pub-id pub-id-type="coi">1:STN:280:DC%2BD3M%2FhsVKjug%3D%3D</pub-id><pub-id pub-id-type="doi">10.1258/0956462001916047</pub-id></mixed-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D’Agoastino</surname><given-names>M</given-names></name><name><surname>Al Habeeb</surname><given-names>A</given-names></name><name><surname>Ghazarian</surname><given-names>D</given-names></name></person-group><article-title xml:lang="en">Cutaneous actinomycosis: the great mimicker</article-title><source>J Clin Pathol</source><year>2009</year><volume>62</volume><issue>8</issue><fpage>765</fpage><lpage>766</lpage><pub-id pub-id-type="doi">10.1136/jcp.2009.067231</pub-id></mixed-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarkonen</surname><given-names>N</given-names></name><name><surname>Könönen</surname><given-names>E</given-names></name><name><surname>Summanen</surname><given-names>P</given-names></name><name><surname>Könönen</surname><given-names>M</given-names></name><name><surname>Jousimies-Somer</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Phenotypic identification of Actinomyces and related species isolated from human sources</article-title><source>J Clin Microbiol</source><year>2001</year><volume>39</volume><issue>11</issue><fpage>3955</fpage><lpage>3961</lpage><pub-id pub-id-type="coi">1:STN:280:DC%2BD3MrnsVymsA%3D%3D</pub-id><pub-id pub-id-type="doi">10.1128/JCM.39.11.3955-3961.2001</pub-id></mixed-citation></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeager</surname><given-names>BA</given-names></name><name><surname>Hoxie</surname><given-names>J</given-names></name><name><surname>Weisman</surname><given-names>RA</given-names></name><name><surname>Greenberg</surname><given-names>MS</given-names></name><name><surname>Bilaniuk</surname><given-names>LT</given-names></name></person-group><article-title xml:lang="en">Actinomycosis in the acquired immunodeficiency syndrome-related complex</article-title><source>Arch Otolaryngol Neck Surg.</source><year>1986</year><volume>112</volume><issue>12</issue><fpage>1293</fpage><lpage>1295</lpage><pub-id pub-id-type="coi">1:STN:280:DyaL2s%2Fis1aksg%3D%3D</pub-id><pub-id pub-id-type="doi">10.1001/archotol.1986.03780120057011</pub-id></mixed-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watkins</surname><given-names>KV</given-names></name><name><surname>Richmond</surname><given-names>AS</given-names></name><name><surname>Langstein</surname><given-names>IM</given-names></name></person-group><article-title xml:lang="en">Nonhealing extraction site due to <italic>Actinomyces naeslundii</italic> in patient with AIDS</article-title><source>Oral Surg Oral Med Oral Pathol.</source><year>1991</year><volume>71</volume><issue>6</issue><fpage>675</fpage><lpage>677</lpage><pub-id pub-id-type="coi">1:STN:280:DyaK3M3ovVShtA%3D%3D</pub-id><pub-id pub-id-type="doi">10.1016/0030-4220(91)90272-E</pub-id></mixed-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manfredi</surname><given-names>R</given-names></name><name><surname>Mazzoni</surname><given-names>A</given-names></name><name><surname>Cavicchi</surname><given-names>O</given-names></name><name><surname>Santini</surname><given-names>D</given-names></name><name><surname>Chiodo</surname><given-names>F</given-names></name></person-group><article-title xml:lang="en">Invasive mycotic and actinomycotic oropharyngeal and craniofacial infection in two patients with AIDS</article-title><source>Mycoses.</source><year>1994</year><volume>37</volume><issue>5–6</issue><fpage>209</fpage><lpage>215</lpage><pub-id pub-id-type="coi">1:STN:280:DyaK2M3gs1ehug%3D%3D</pub-id><pub-id pub-id-type="doi">10.1111/j.1439-0507.1994.tb00302.x</pub-id></mixed-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kingdom</surname><given-names>TT</given-names></name><name><surname>Tami</surname><given-names>TA</given-names></name></person-group><article-title xml:lang="en">Actinomycosis of the nasal septum in a patient infected with the human immunodeficiency virus</article-title><source>Otolaryngol Neck Surg.</source><year>1994</year><volume>111</volume><issue>1</issue><fpage>130</fpage><lpage>133</lpage><pub-id pub-id-type="coi">1:STN:280:DyaK2czgtFKqsw%3D%3D</pub-id><pub-id pub-id-type="doi">10.1177/019459989411100123</pub-id></mixed-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manfredi</surname><given-names>R</given-names></name><name><surname>Mazzoni</surname><given-names>A</given-names></name><name><surname>Marinacci</surname><given-names>G</given-names></name><name><surname>Nanetti</surname><given-names>A</given-names></name><name><surname>Chiodo</surname><given-names>F</given-names></name></person-group><article-title xml:lang="en">Progressive intractable actino mycosis in patients with AIDS</article-title><source>Scand J Infect Dis.</source><year>1995</year><volume>1</volume><fpage>405</fpage><lpage>407</lpage><pub-id pub-id-type="doi">10.3109/00365549509032741</pub-id></mixed-citation></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vazquez</surname><given-names>AM</given-names></name><name><surname>Marti</surname><given-names>C</given-names></name><name><surname>Reñaga</surname><given-names>I</given-names></name><name><surname>Salavert</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Actinomycosis of the tongue associated with human immunodeficiency virus infection: case report</article-title><source>J Oral Maxillofac Surg</source><year>1997</year><volume>55</volume><issue>8</issue><fpage>879</fpage><lpage>881</lpage><pub-id pub-id-type="coi">1:STN:280:DyaK2szpsFCrsQ%3D%3D</pub-id><pub-id pub-id-type="doi">10.1016/S0278-2391(97)90354-2</pub-id></mixed-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spadari</surname><given-names>F</given-names></name><name><surname>Tartaglia</surname><given-names>GM</given-names></name><name><surname>Spadari</surname><given-names>E</given-names></name><name><surname>Fazio</surname><given-names>N</given-names></name></person-group><article-title xml:lang="en">Oral actinomycosis in acquired immunode<sup>®</sup>ciency syndrome</article-title><source>Int J STD AIDS.</source><year>1998</year><volume>9</volume><fpage>424</fpage><lpage>426</lpage><pub-id pub-id-type="coi">1:STN:280:DyaK1czlvFeruw%3D%3D</pub-id><pub-id pub-id-type="doi">10.1258/0956462981922412</pub-id><pub-id pub-id-type="pmid">9696200</pub-id></mixed-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ablanedo-Terrazas</surname><given-names>Y</given-names></name><name><surname>Ormsby</surname><given-names>CE</given-names></name><name><surname>Reyes-Terán</surname><given-names>G</given-names></name></person-group><article-title xml:lang="en">Palatal actinomycosis and kaposi sarcoma in an HIV-infected subject with disseminated mycobacterium avium-intracellulare infection</article-title><source>Case Rep Med.</source><year>2012</year><volume>2012</volume><fpage>1</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1155/2012/679728</pub-id></mixed-citation></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sudhakar</surname><given-names>SS</given-names></name><name><surname>Ross</surname><given-names>JJ</given-names></name></person-group><article-title xml:lang="en">Short-term treatment of actinomycosis: two cases and a review</article-title><source>Clin Infect Dis.</source><year>2004</year><volume>38</volume><issue>3</issue><fpage>444</fpage><lpage>447</lpage><pub-id pub-id-type="doi">10.1086/381099</pub-id></mixed-citation></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>M</given-names></name><name><surname>Carrard</surname><given-names>VC</given-names></name><name><surname>Munerato</surname><given-names>MC</given-names></name></person-group><article-title xml:lang="en">Cervicofacial actinomycosis of the maxilla and HIV infection: a case report</article-title><source>Otolaryngology.</source><year>2017</year><volume>07</volume><issue>01</issue><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.4172/2161-119X.1000288</pub-id></mixed-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cendan</surname><given-names>I</given-names></name><name><surname>Klapholz</surname><given-names>A</given-names></name><name><surname>Talavera</surname><given-names>W</given-names></name></person-group><article-title xml:lang="en">A cause of endobronchial disease in a patient with AIDS</article-title><source>Chest.</source><year>1993</year><volume>103</volume><issue>6</issue><fpage>1886</fpage><lpage>1887</lpage><pub-id pub-id-type="coi">1:STN:280:DyaK2c%2FgvVSnug%3D%3D</pub-id><pub-id pub-id-type="doi">10.1378/chest.103.6.1886</pub-id></mixed-citation></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tabarsi</surname><given-names>P</given-names></name><name><surname>Yousefi</surname><given-names>S</given-names></name><name><surname>Jabbehdari</surname><given-names>A</given-names></name><name><surname>Sayena</surname><given-names>A</given-names></name><etal/></person-group><article-title xml:lang="en">Pulmonary actinomycosis in a patient with AIDS/HCV</article-title><source>J Clin Diagn Res.</source><year>2017</year><volume>11</volume><issue>6</issue><fpage>15</fpage><lpage>17</lpage></mixed-citation></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spencer</surname><given-names>GM</given-names></name><name><surname>Roach</surname><given-names>D</given-names></name><name><surname>Skucas</surname><given-names>J</given-names></name></person-group><article-title xml:lang="en">Actinomycosis of the esophagus in a patient with AIDS: findings on barium esophagograms</article-title><source>Am J Roentgenol</source><year>1993</year><volume>161</volume><issue>4</issue><fpage>795</fpage><lpage>796</lpage><pub-id pub-id-type="coi">1:STN:280:DyaK3szotlOqsg%3D%3D</pub-id><pub-id pub-id-type="doi">10.2214/ajr.161.4.8372761</pub-id></mixed-citation></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Litt</surname><given-names>I</given-names></name><name><surname>Levine</surname><given-names>S</given-names></name><name><surname>Maki</surname><given-names>D</given-names></name><name><surname>Sachdeva</surname><given-names>RM</given-names></name><name><surname>Einhorn</surname><given-names>E</given-names></name></person-group><article-title xml:lang="en">Ileal actinomycosis in a patient with AIDS</article-title><source>AJR.</source><year>1999</year><volume>1</volume><fpage>1297</fpage><lpage>1299</lpage><pub-id pub-id-type="doi">10.2214/ajr.172.5.10227506</pub-id></mixed-citation></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arora</surname><given-names>AK</given-names></name><name><surname>Nord</surname><given-names>J</given-names></name><name><surname>Olofinlade</surname><given-names>O</given-names></name></person-group><article-title xml:lang="en">Esophageal actinomycosis : a case report and review of the literature</article-title><source>Dysphagia.</source><year>2003</year><volume>18</volume><issue>1</issue><fpage>27</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1007/s00455-002-0080-5</pub-id></mixed-citation></ref><ref id="CR24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Redelman-sidi</surname><given-names>G</given-names></name><name><surname>Patel</surname><given-names>M</given-names></name><name><surname>Dimaio</surname><given-names>C</given-names></name><etal/></person-group><article-title xml:lang="en">Esophageal actinomycosis in a fifty-three-year-old man</article-title><source>AIDS Patient Care STDS.</source><year>2010</year><volume>24</volume><fpage>2</fpage></mixed-citation></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomes</surname><given-names>J</given-names></name><name><surname>Pereira</surname><given-names>T</given-names></name><name><surname>Carvalho</surname><given-names>A</given-names></name><name><surname>Brito</surname><given-names>C</given-names></name></person-group><article-title xml:lang="en">Primary cutaneous actinomycosis caused by as first manifestation of HIV infection</article-title><source>Dermatol Online J.</source><year>2011</year><volume>17</volume><fpage>11</fpage></mixed-citation></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abrahamian</surname><given-names>FM</given-names></name><name><surname>Goldstein</surname><given-names>EJC</given-names></name></person-group><article-title xml:lang="en">Microbiology of animal bite wound infections</article-title><source>Clin Microbiol Rev</source><year>2011</year><volume>24</volume><issue>2</issue><fpage>231</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1128/CMR.00041-10</pub-id></mixed-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metgud</surname><given-names>SC</given-names></name></person-group><article-title xml:lang="en">Primary cutaneous actinomycosis: A rare soft tissue infection</article-title><source>Indian Journal of Medical Microbiology</source><year>2008</year><volume>26</volume><issue>2</issue><fpage>184</fpage><pub-id pub-id-type="coi">1:STN:280:DC%2BD1c3otlKqtA%3D%3D</pub-id><pub-id pub-id-type="doi">10.4103/0255-0857.40540</pub-id></mixed-citation></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="other">Roy D, Roy PG, Misra PK. An interesting case of primary cutaneous actinomycosis. Dermatol Online J. 2003;9(5). <ext-link xlink:href="https://escholarship.org/uc/item/9x96h2pz#main" ext-link-type="url">https://escholarship.org/uc/item/9x96h2pz#main</ext-link>.</mixed-citation></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Isenberg</surname><given-names>HD</given-names></name></person-group><source>Clinical microbiology procedures handbook</source><year>2004</year><edition>2</edition><publisher-loc>Washington Dc</publisher-loc><publisher-name>ASM Press</publisher-name></mixed-citation></ref><ref id="CR30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Georg</surname><given-names>LK</given-names></name><name><surname>Robertstad</surname><given-names>GW</given-names></name><name><surname>Brinkman</surname><given-names>SA</given-names></name></person-group><article-title xml:lang="en">Identification of species of actinomyces</article-title><source>J Bacteriol</source><year>1964</year><volume>88</volume><issue>2</issue><fpage>477</fpage><lpage>490</lpage><pub-id pub-id-type="coi">1:STN:280:DyaF2M%2FgslOnsQ%3D%3D</pub-id><pub-id pub-id-type="pmid">14203367</pub-id><pub-id pub-id-type="pmcid">277325</pub-id></mixed-citation></ref><ref id="CR31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robati</surname><given-names>RM</given-names></name><name><surname>Niknezhad</surname><given-names>N</given-names></name><name><surname>Bidari-Zerehpoush</surname><given-names>F</given-names></name><name><surname>Niknezhad</surname><given-names>N</given-names></name></person-group><article-title xml:lang="en">Primary cutaneous actinomycosis along with the surgical scar on the hand</article-title><source>Case Rep Infect Dis.</source><year>2016</year><volume>2016</volume><fpage>1</fpage><lpage>3</lpage></mixed-citation></ref><ref id="CR32"><label>32.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Booth</surname><given-names>S.J.</given-names></name></person-group><article-title>Diseases Caused by Actinomyces Species☆</article-title><source>Reference Module in Biomedical Sciences</source><year>2014</year></mixed-citation></ref><ref id="CR33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steininger</surname><given-names>C</given-names></name><name><surname>Willinger</surname><given-names>B</given-names></name></person-group><article-title xml:lang="en">Resistance patterns in clinical isolates of pathogenic Actinomyces species</article-title><source>J Antimicrob Chemother</source><year>2016</year><volume>71</volume><issue>2</issue><fpage>422</fpage><lpage>427</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XksFagsb8%3D</pub-id><pub-id pub-id-type="doi">10.1093/jac/dkv347</pub-id></mixed-citation></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akhtar</surname><given-names>M</given-names></name><name><surname>Zade</surname><given-names>MP</given-names></name><name><surname>Shahane</surname><given-names>PL</given-names></name><name><surname>Bangde</surname><given-names>AP</given-names></name><name><surname>Soitkar</surname><given-names>SM</given-names></name></person-group><article-title xml:lang="en">Scalp actinomycosis presenting as soft tissue tumour: a case report with literature review</article-title><source>Int J Surg Case Rep.</source><year>2015</year><volume>16</volume><fpage>99</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1016/j.ijscr.2015.09.030</pub-id><pub-id pub-id-type="pmid">26439419</pub-id><pub-id pub-id-type="pmcid">4643463</pub-id></mixed-citation></ref><ref id="CR35"><label>35.</label><mixed-citation publication-type="other">S R. Australian Medicines Handbook. 2006th ed. Adelaide: Australian Medicines Handbook.</mixed-citation></ref></ref-list></ref-list><glossary><title>Abbreviations</title><def-list><def-item><term>ATT</term><def><p id="Par4">anti-tubercular treatment</p></def></def-item><def-item><term>CLSI</term><def><p id="Par5">Clinical and Laboratory Standard Institute</p></def></def-item><def-item><term>CT</term><def><p id="Par6">computerized tomography</p></def></def-item><def-item><term>HBsAg</term><def><p id="Par7">hepatitis B surface antigen</p></def></def-item><def-item><term>HCV</term><def><p id="Par8">hepatitis C Virus</p></def></def-item><def-item><term>HIV</term><def><p id="Par9">human immunodeficiency virus</p></def></def-item><def-item><term>PLHA</term><def><p id="Par10">people living with HIV/AIDS</p></def></def-item><def-item><term>TMP–SMX</term><def><p id="Par11">trimethoprim–sulfamethoxazole</p></def></def-item></def-list></glossary><notes notes-type="Misc"><title>Publisher's Note</title><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></notes></back></article></records><facets><facet name="subject"><facet-value count="1">Infectious Diseases</facet-value><facet-value count="1">Medicine &amp; Public Health</facet-value><facet-value count="1">Virology</facet-value></facet><facet name="keyword"><facet-value count="1">AIDS</facet-value><facet-value count="1">Diagnostic consideration</facet-value><facet-value count="1">Penicillin</facet-value><facet-value count="1">Primary cutaneous actinomycosis</facet-value></facet><facet name="pub"><facet-value count="1">AIDS Research and Therapy</facet-value></facet><facet name="year"><facet-value count="1">2019</facet-value></facet><facet name="country"><facet-value count="1">Nepal</facet-value></facet><facet name="type"><facet-value count="1">Journal</facet-value></facet></facets></response>
